Hangzhou Tigermed Consulting Co., Ltd. (300347)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
54. 97
+0.62
+1.1408%
¥
42.02B Market Cap
- P/E Ratio
1.2% Div Yield
34.94M Volume
- Eps
¥ 54.35
Previous Close Want to track 300347 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.17 | - |
| | | 0.34 | 0.74 |
| | | 0.35 | 0.26 |
| | | 0.22 | - |
| | | - | - |
| | | 0.56 | 0.3 |
| | | 0.53 | 0.27 |
| | | 0.68 | - |
| | | 0.46 | 0.17 |
| | | 0.75 | 0.57 |
| | | - | 0.03 |
| | | - | 0.05 |
| | | - | 0.06 |
| | | - | 0.07 |
| | | - | 0.05 |
| | | - | 0.06 |
| | | - | 0.06 |
| | | - | 0.05 |
| | | - | 0.04 |
300347 Earnings Reports FAQ
What is the earnings per share (EPS) for 300347?
EPS data for 300347 is currently not available, as Hangzhou Tigermed Consulting Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 29.55%, reflecting the 300347's performance and XSHE market conditions.
When is the next earnings release date?
Hangzhou Tigermed Consulting Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Hangzhou Tigermed Consulting Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 300347 at this time, as Hangzhou Tigermed Consulting Co., Ltd has no recent EPS data to calculate it.
